Renamed First Light Diagnostics in December 2018 - from First Light Biosciences - the firm is developing novel automated medical diagnostics products offering a combination of sensitivity, accuracy, cost-effectiveness, and ease-of-use. Based on the firm's proprietary MultiPath imaging technology that counts molecules and cells without magnification. First Light is developing the first system for large scale testing and triage after a major bioterrorism attack or infectious disease outbreak. This unique system addresses a critical gap in public health preparedness that could lead to thousands of needless deaths due to inefficient targeting of medical resources in a crisis. First Light's product pipeline strategy targets the large and growing market for routine hospital testing, and includes a powerful new test for microbes causing hospital acquired infections
